Company intelligence / Profile preview

AipGene Therapeutics

Gurugram, Haryana, India
Ownership
Private
Development stage
Other
01

Overview

AIGen Therapeutics is an Indian biotechnology startup that leverages advanced artificial intelligence and deep learning platforms to discover and develop novel therapies for high-unmet-need genetic and infectious diseases. Founded in 2019 and headquartered in Gurugram, the company operates as a full-stack biotech, combining computational discovery with in-house wet-lab validation and supercomputing power. Its proprietary AI platform analyzes massive proteomic and genomic datasets to design first-in-class biologics, antibodies, and therapeutic peptides. AIGen currently advances a diverse pipeline of candidates through strategic research collaborations with academic institutions, including Panjab University and the NCR Biotech Science Cluster.

Therapeutic areas
OncologyRare DiseasesInfectious Diseases
Modalities
BiologicMonoclonal antibodyPeptidesEnzyme replacement therapyProtein
Industry
Biotech
02

Partnerships

NCR Biotech Science ClusterRegional Centre for Biotechnology (RCB)

Beyond the preview

Go deeper on AipGene Therapeutics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on AipGene Therapeutics.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call